MITOTHERAPEUTIX LLC SBIR Phase II Award, May 2022
A SBIR Phase II contract was awarded to Mitotherapeutix LLC in May, 2022 for $860,261.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
860,261
0
Government Branch
Date Awarded
May 1, 2022
0
End Date
January 31, 2024
0
SBIR/STTR Award Recipient
Contract Number (US Government)
4R44DK129102-02
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like MITOTHERAPEUTIX LLC SBIR Phase II Award, May 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.